Privia Health Group, INC Form 4 insider transactions

Privia Health Group, Inc. Director Thomas A. McCarthy was granted 8,396 restricted stock units on May 21, 2025, as part of the company's 2021 Omnibus Incentive Plan.

Privia Health Group, Inc. Director David P. King reported the acquisition of 8,396 restricted stock units as part of the company's 2021 Omnibus Incentive Plan.

Privia Health Group, Inc. Director David S. Wichmann was granted 8,396 restricted stock units on May 21, 2025, increasing his direct beneficial ownership.

Privia Health Group, Inc. Director Nancy G. Cocozza was granted 8,396 restricted stock units as part of the company's 2021 Omnibus Incentive Plan.

Privia Health Group, Inc. Director Pamela O. Kimmet was granted 8,396 restricted stock units (RSUs) on May 21, 2025, as part of the company's 2021 Omnibus Incentive Plan.

Privia Health Group, Inc. Director Patricia Anne Maryland was granted 8,396 restricted stock units on May 21, 2025, as part of the company's 2021 Omnibus Incentive Plan.

Privia Health Group, Inc. Director Jaewon Ryu was granted 8,396 restricted stock units as part of the company's 2021 Omnibus Incentive Plan.

Privia Health Group, Inc. Director Matthew Shawn Morris was granted 8,396 restricted stock units as part of the company's 2021 Omnibus Incentive Plan.

Privia Health Group's CEO, Parth Mehrotra, sold shares on May 12th and 13th, 2025, to cover tax obligations related to vesting restricted stock units and under a pre-arranged 10b5-1 trading plan.

David Mountcastle, EVP & Chief Financial Officer of Privia Health Group, sold shares to cover tax withholding obligations related to vesting restricted stock units.

Director Matthew Shawn Morris sold 10,309 shares of Privia Health Group, Inc. to cover tax obligations related to vesting restricted stock units.

David Mountcastle, EVP & Chief Financial Officer of Privia Health Group, sold 3,445 shares of common stock to cover tax obligations related to vesting restricted stock units.

Privia Health Group's CEO, Parth Mehrotra, sold shares on April 30, 2025 and May 1, 2025 to cover tax obligations and pursuant to a pre-arranged 10b5-1 trading plan.

David Mountcastle, EVP & Chief Financial Officer of Privia Health Group, sold 5,630 shares of common stock on April 2, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Privia Health Group's CEO, Parth Mehrotra, sold 10,514 shares of common stock at $24.03 per share on March 12, 2025, under a pre-arranged 10b5-1 trading plan.

Privia Health Group's CEO, Parth Mehrotra, sold shares to cover tax withholding obligations related to the vesting and settlement of restricted stock units.

David Mountcastle, EVP & Chief Financial Officer of Privia Health Group, reported the sale of common stock to cover tax withholding obligations related to the vesting of restricted stock units.

Edward C. Fargis, EVP & General Counsel of Privia Health Group, Inc., sold shares to cover tax withholding obligations related to the vesting and settlement of restricted stock units.

Edward C Fargis, EVP & General Counsel of Privia Health Group, reports acquiring and disposing of common stock on March 5, 2025.

EVP and Chief Financial Officer of Privia Health Group, David Mountcastle, reports the acquisition of restricted stock units and a change in beneficial ownership of common stock.

Privia Health Group's CEO, Parth Mehrotra, reports acquiring and disposing of common stock on March 5, 2025, according to a Form 4 filing.

David Mountcastle, EVP & Chief Financial Officer of Privia Health Group, Inc., sold 100,000 shares of common stock at an average price of $25.15 on February 14, 2025, according to a Form 4 filing.

Privia Health Group's CEO, Parth Mehrotra, executed stock options and sold a portion of the acquired shares to cover exercise costs and tax obligations, while retaining the remaining shares.

Director Matthew Shawn Morris' spouse transferred her interest in Emerald Family, LLC, holding Privia Health Group shares and options, to a family trust.

Director Thomas A. McCarthy transferred 41,487 shares of Privia Health Group, Inc. common stock to a family trust on August 21, 2024.

Director Adam Boehler reported the acquisition of 364 shares of Privia Health Group, Inc. at a price of $16.5 per share on June 11, 2024.

Director Adam Boehler reports the purchase of 5,306 shares of Privia Health Group, Inc. at a weighted average price of $16.50.

Director Adam Boehler reports purchasing 4,280 shares of Privia Health Group at an average price of $16.49.

Director Patricia Maryland received 11,124 restricted stock units in Privia Health Group, Inc. on May 22, 2024, under the company's 2021 Omnibus Incentive Plan.

Director David P. King reports acquiring 11,124 shares of Privia Health Group common stock through restricted stock units and disposing of 33,916 shares.